Fig. 2: Effect of piR-28846 expression on the growth of 3D organoid model of ovarian cancer.
From: piRNA28846 has the potential to be a novel RNA nucleic acid drug for ovarian cancer
Addition of agopiR-28846 to the ovarian cancer organoid model for treatment resulted in a significant reduction in growth rate in the treated group compared to the control group(n = 13).
